The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trialNadine Rouphael, Wendy Nesheim, Devin V. McAllister et al.|The Lancet|2017Cited by 423
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trialsMyra Happe, Jamie Sanders, Amelia R. Hofstetter et al.|npj Vaccines|2024Cited by 19